0 Ratings

ID

22457

Description

Study part: Study conclusion.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Keywords

  1. 6/5/17 6/5/17 -
Copyright Holder

GlaxoSmithKline

Uploaded on

June 5, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :


    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Study conclusion Mepolizumab HES NCT00086658

    Study conclusion

    1. StudyEvent: ODM
      1. Study conclusion
    STUDY CONCLUSION
    Description

    STUDY CONCLUSION

    Alias
    UMLS CUI-1
    C1707478
    UMLS CUI-2
    C0008972
    Subject ID
    Description

    Subject ID

    Data type

    text

    Alias
    UMLS CUI [1]
    C2348585
    Date of subject completion or withdrawal
    Description

    Date of subject completion or withdrawal

    Data type

    date

    Alias
    UMLS CUI [1]
    C2983670
    Was the subject withdrawn from the study?
    Description

    Study Subject Participation Status

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C2348568
    The primary reason for withdrawal:
    Description

    reason study conclusion

    Data type

    text

    Alias
    UMLS CUI [1,1]
    C0392360
    UMLS CUI [1,2]
    C1707478
    UMLS CUI [1,3]
    C0008972
    If other, please specify
    Description

    Other

    Data type

    text

    Alias
    UMLS CUI [1]
    C0205394

    Similar models

    Study conclusion

    1. StudyEvent: ODM
      1. Study conclusion
    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    STUDY CONCLUSION
    C1707478 (UMLS CUI-1)
    C0008972 (UMLS CUI-2)
    Subject ID
    Item
    Subject ID
    text
    C2348585 (UMLS CUI [1])
    Date of subject completion or withdrawal
    Item
    Date of subject completion or withdrawal
    date
    C2983670 (UMLS CUI [1])
    Study Subject Participation Status
    Item
    Was the subject withdrawn from the study?
    boolean
    C2348568 (UMLS CUI [1])
    Item
    The primary reason for withdrawal:
    text
    C0392360 (UMLS CUI [1,1])
    C1707478 (UMLS CUI [1,2])
    C0008972 (UMLS CUI [1,3])
    Code List
    The primary reason for withdrawal:
    CL Item
    Adverse event (record details on the Non-Serious Adverse Event or Serious Adverse Event pages as appropriate) (Adverse event (record details on the Non-Serious Adverse Event or Serious Adverse Event pages as appropriate))
    C0877248 (UMLS CUI-1)
    CL Item
    Lost to follow-up (Lost to follow-up)
    C1302313 (UMLS CUI-1)
    CL Item
    Protocol violation (Protocol violation)
    C1709750 (UMLS CUI-1)
    CL Item
    Subject decided to withdraw from the study (Subject decided to withdraw from the study)
    C2348571 (UMLS CUI-1)
    CL Item
    Lack of efficacy (Lack of efficacy)
    C0235828 (UMLS CUI-1)
    CL Item
    Sponsor terminated study (Sponsor terminated study)
    C1710224 (UMLS CUI-1)
    CL Item
    Disease progression (Disease progression)
    C0242656 (UMLS CUI-1)
    CL Item
    Other, specify (Other, specify)
    C0205394 (UMLS CUI-1)
    Other
    Item
    If other, please specify
    text
    C0205394 (UMLS CUI [1])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial